The cardioprotective effects of GLP-1 RAs in patients diagnosed with type 2 diabetes, alongside associated reductions in cardiovascular risk factors, such as glycated hemoglobin level and BMI are now further elucidated by our findings17,22,26. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.